Literature DB >> 23163136

[The screening and the functional pathway analysis of differential genes correlated with coronary heart disease of blood stasis syndrome].

Zhao-kai Yuan1, Li-ping Wang, Xian-ping Huang.   

Abstract

OBJECTIVE: To explore the function and target pathway of the correlated differential gene of coronary heart disease (CHD) of blood stasis syndrome (BSS).
METHODS: Patients of the genealogical CHD of BSS (group A) and the genealogical CHD of non-BSS (group B), the genealogical non-CHD of BSS (group C), the genealogical healthy subjects (group D), the non-genealogical CHD of BSS (group E), the non-genealogical healthy subjects (group F) were recruited in this study. The differential gene expression spectrums were studied using gene chip technique. The molecular functions of differential genes were analyzed and illustrated by gene ontology (GO) analysis. The differential gene pathways were found out at BioCarta and KEGG. The meaningful target pathways were screened by hypergeometric distribution statistical method. The differential genes were verified using Real-time fluorescent quantitative PCR.
RESULTS: (1) By screening the gene chip data (with FC > or =3), we found the expressions of differential genes of CHD of BSS were mainly involved in chemokine, interleukin cytokine, alexin system, matrix metal proteinase system, fibroblastic growth factor, endothelial cell adhesion molecule, and so on. (2) By GO analysis of related differential genes (P < 0.05), we found the molecular functions of differential genes associated with CHD BSS. (3) By BioCarta and KEGG pathway analysis, we found the target pathways of the hereditary correlated differential genes of CHD BSS with significance were mainly involved in inflammation, plaque formation, endothelial injury, and so on. The results of Real-time fluorescent quantitative RT-PCR proved the accuracy of the gene chip.
CONCLUSION: The hereditary correlated differential genes of CHD BSS were closely associated with inflammation, plaque formation, and endothelial injury.

Entities:  

Mesh:

Year:  2012        PMID: 23163136

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  8 in total

Review 1.  Accelerated RBC senescence as a novel pathologic mechanism of blood stasis syndrome in traditional East Asian medicine.

Authors:  Sooseong You; Bongki Park; Myeong Soo Lee
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

2.  Conceptualization and utilization of blood stasis syndrome among doctors of Korean medicine: results of a web-based survey.

Authors:  Bongki Park; Kyung-Jin Yun; Jeeyoun Jung; Sooseong You; Ju Ah Lee; Jiae Choi; Byoung-Kab Kang; Terje Alraek; Stephen Birch; Myeong Soo Lee
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

Review 3.  Integrative Western and chinese medicine on coronary heart disease: where is the orientation?

Authors:  Siming Li; Hao Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

4.  Clinical Applications of Omics Technologies on ZHENG Differentiation Research in Traditional Chinese Medicine.

Authors:  Ya-Nan Song; Gui-Biao Zhang; Yong-Yu Zhang; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-18       Impact factor: 2.629

Review 5.  Korean studies on blood stasis: an overview.

Authors:  Bongki Park; Sooseong You; Jeeyoun Jung; Ju Ah Lee; Kyung-Jin Yun; Myeong Soo Lee
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

6.  Differential gene expression profiles between two subtypes of ischemic stroke with blood stasis syndromes.

Authors:  Tian-Long Liu; Min-Na Liu; Xin-Liang Xu; Wen-Xing Liu; Pei-Jin Shang; Xiao-Hu Zhai; Hang Xu; Yi Ding; Yu-Wen Li; Ai-Dong Wen
Journal:  Oncotarget       Date:  2017-12-04

7.  Association of serum resistin with blood stasis syndrome in traditional Korean medicine for metabolic diseases: A cross-sectional multicenter observational study.

Authors:  Mi Mi Ko; Min Ho Cha; Jeeyoun Jung
Journal:  Integr Med Res       Date:  2021-02-13

8.  ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine.

Authors:  Jianye Dai; Junwei Fang; Shujun Sun; Qiwen Chen; Huijuan Cao; Ningning Zheng; Yongyu Zhang; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-03       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.